EV/EBITDA:
9.65-0.10(-1.03%)Summary
- As of today (June 25, 2025), SUPN EV/EBITDA is 9.65, with a fall of -0.10 (-1.03%) during the most recent trading session on June 24, 2025.
- Over the past year, SUPN EV/EBITDA has dropped by -8.60 (-47.12%).
- SUPN EV/EBITDA is now -88.67% below its all-time high of 85.14.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.0% | -1.1% | -1.0% |
| 1 m1 month | -1.4% | -1.4% | -1.3% |
| 3 m3 months | - | - | -3.1% |
| 6 m6 months | -23.8% | -14.3% | -11.0% |
| ytdytd | -13.1% | -14.7% | -12.4% |
| 1 y1 year | -47.1% | +15.9% | +17.7% |
| 5 y5 years | +27.0% | +22.4% | +36.0% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 10.16 | -5.0% | 9.65 | at low |
| 3 m | 3-month | 10.21 | -5.5% | 9.42 | +2.4% |
| 6 m | 6-month | 13.23 | -27.1% | 9.42 | +2.4% |
| 1 y | 1-year | 18.25 | -47.1% | 9.42 | +2.4% |
| 3 y | 3-year | 23.20 | -58.4% | 9.42 | +2.4% |
| 5 y | 5-year | 23.20 | -58.4% | 5.50 | +75.5% |
| alltime | all time | 85.14 | -88.7% | -144.43 | +106.7% |
SUPN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 9.65(-13.1%) |
| 2024 | 11.11(-35.4%) |
| 2023 | 17.21(+15.4%) |
| 2022 | 14.91(+8.4%) |
| 2021 | 13.75(+99.3%) |
| 2020 | 6.90(-15.4%) |
| 2019 | 8.16(-28.0%) |
| Date | Value |
|---|---|
| 2018 | 11.34(-35.7%) |
| 2017 | 17.63(-15.0%) |
| 2016 | 20.73(-33.4%) |
| 2015 | 31.14(-133.7%) |
| 2014 | -92.53(+2456.1%) |
| 2013 | -3.62(-25.1%) |
| 2012 | -4.83 |
FAQ
- What is Supernus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of SUPN is 9.65
What is the all time high EV/EBITDA for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high EV/EBITDA is 85.14
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals EV/EBITDA has changed by -1.46 (-13.14%) since the beginning of the year
What is Supernus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by -8.60 (-47.12%)